Skip to content

Early and late effects of 24 hours supplemental parenteral amino acids on whole-body protein turnover in critically ill patients.

Early and late effects of 24 hours supplemental parenteral amino acids on whole-body protein turnover in critically ill patients.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615001314516
Enrollment
12
Registered
2015-12-01
Start date
2016-01-12
Completion date
2016-05-12
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Critical ill patients loose lean body and muscle mass at a high rate. This fast wasting is related to a worsened clinical outcome. Appropriate protein feeding might prevent or reduce the wasting and thereby affect outcome. However, the best amount of protein for this is not well characterized. In a previous study we have shown that an 3 hour parenteral supplementation of amino acid to these patients results in a positive protein balance and that the extra amino acids are not oxidizes (Liebau et al. Crit Care 2015, 19:106.). The aim of the present study is to investigate if this effect persists over a longer time and therefore measurements of protein balance and oxidation are performed during 24 hours of supplementation after both 3 and 24 hours.

Interventions

Critical patients treated in a medical/surgical ICU or intermediary unit will receive supplemental parenteral amino acids in addition to their ongoing nutrition. The supplemental amino acids will be given as an equivalent of 1 gram protein/kg body weight per day for 24 hours. A mixture of amino acids (Glavamin, Fresenius) will be infused at a continuous rate of 0.083 g/kg/h for 24 hours. Infusion rates for the supplement will be automatically registered in the on-line clinical management system

Critical patients treated in a medical/surgical ICU or intermediary unit will receive supplemental parenteral amino acids in addition to their ongoing nutrition. The supplemental amino acids will be given as an equivalent of 1 gram protein/kg body weight per day for 24 hours. A mixture of amino acids (Glavamin, Fresenius) will be infused at a continuous rate of 0.083 g/kg/h for 24 hours. Infusion rates for the supplement will be automatically registered in the on-line clinical management system (ClinSoft). Measurements of whole-body protein kinetics is performed just before supplementation and at 3 and 24 hours after start of the supplementation.

Sponsors

Olav Rooyackers
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Critically ill patients with expected stable nutrition for 30 hours.

Exclusion criteria

Ongoing dialysis

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026